The sociodemographic characteristics and dietary and blood plasma fatty acid profiles of elderly Saudi women with Alzheimer disease

Table 3 Fatty acid profile of plasma in control and AD* patients

Fatty acid from plasma (g/day)	National Guard Health Affairs- King Abdulaziz Medical City, Riyadh (NGH)		Social Welfare Homes for the Elderly (SWH)
	Control	Alzheimer	Control	Alzheimer
LA (Linoleic acid; C18:2)	2.423 ± 0.1532^Aa	1.554 ± 0.1500^Aa	1.899 ± 1.001^Aa	01.756 ± 0.1080^Aa
AA (Arachidonic acid; C20:4)	0.019 ± 0.0007^Aa	0.002 ± 0.018^Aa	0.017 ± 0.001^Aa	0.017 ± 0.001^Aa
ALA (α-linolenic acid; C18:3)	18.17 ± 1.165^Aa	11.57 ± 1.1400^Aa	14.24 ± 0.7520^Aa	13.19 ± 0.8085^Aa
EPA (Eicosapentaenoic acid; C20:5)	0.158 ± 0.0172^Aa	0.111 ± 0.0086^Aab	0.109 ± 0.0067^Aab	0.083 ± 0.0032^Ab
DHA (Docosahexaenoic acid; C22:6)	0.460 ± 0.0421^Aa	0.377 ± 0.0360^Aa	0.352 ± 0.0206^Aa	0.403 ± 0.0226^Aa
Total ω-6	2.442 ± 0.1536^Aa	1.572 ± 0.1501^Aa	1.916 ± 0.1001^Aa	1.773 ± 0.1080^Aa
Total ω-3	18.78 ± 11.95 ^Aa	12.05 ± 1.1738^Aa	14.71 ± 0.7710^Aa	13.68 ± 0.8284^Aa
ω-6/ ω-3	0.137 ± 0.0021^Ab	0.174 ± 0.0102^Aa	0.130 ± 0.004^Ab	0.006 ± 0.12^Ab

*AD-Alzheimer disease
Results are reported in mean ± standard deviation
^abDifferent superscripts denote a statistically significant difference between controls of two different places and between Alzheimer patients of two places
^A superscripts denote a statistically significant difference between controls and Alzheimers patients of each place individually

ISSN: 1476-511X